COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.
Saved in:
| Title: | COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients. |
|---|---|
| Authors: | Stewart M; Friends of Cancer Research, Washington, District of Columbia, United States of America., Rodriguez-Watson C; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America., Albayrak A; Health Catalyst, Salt Lake City, Utah, United States of America., Asubonteng J; Gilead Science, Inc. Foster City, California, United States of America., Belli A; COTA, Inc., Boston, Massachusetts, United States of America., Brown T; Syapse, San Francisco, California, United States of America., Cho K; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America., Das R; Dascena, Oakland, California, United States of America., Eldridge E; Health Catalyst, Salt Lake City, Utah, United States of America., Gatto N; Aetion, New York, New York, United States of America., Gelman A; Health Catalyst, Salt Lake City, Utah, United States of America., Gerlovin H; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America., Goldberg SL; Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America., Hansen E; COTA, Inc., Boston, Massachusetts, United States of America., Hirsch J; Syapse, San Francisco, California, United States of America., Ho YL; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America., Ip A; Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America., Izano M; Syapse, San Francisco, California, United States of America., Jones J; Health Catalyst, Salt Lake City, Utah, United States of America., Justice AC; VA Connecticut Healthcare System, West Haven, Connecticut, United States of America.; Yale University Schools of Medicine and Public Health, New Haven, Connecticut, United States of America., Klesh R; HealthVerity, Philadelphia, Pennsylvania, United States of America., Kuranz S; TriNetX, Cambridge, Massachusetts, United States of America., Lam C; Dascena, Oakland, California, United States of America., Mao Q; Dascena, Oakland, California, United States of America., Mataraso S; Dascena, Oakland, California, United States of America., Mera R; Gilead Science, Inc. Foster City, California, United States of America., Posner DC; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America., Rassen JA; Aetion, New York, New York, United States of America., Siefkas A; Dascena, Oakland, California, United States of America., Schrag A; Syapse, San Francisco, California, United States of America., Tourassi G; National Center for Computational Sciences Oak Ridge National Laboratory, Oak Ridge, Tennessee, United States of America., Weckstein A; Aetion, New York, New York, United States of America., Wolf F; Syapse, San Francisco, California, United States of America., Bhat A; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America., Winckler S; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America., Sigal EV; Friends of Cancer Research, Washington, District of Columbia, United States of America.; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America., Allen J; Friends of Cancer Research, Washington, District of Columbia, United States of America. |
| Source: | PloS one [PLoS One] 2021 Mar 17; Vol. 16 (3), pp. e0248128. Date of Electronic Publication: 2021 Mar 17 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33730088 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Stewart+M%22">Stewart M</searchLink>; Friends of Cancer Research, Washington, District of Columbia, United States of America.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Watson+C%22">Rodriguez-Watson C</searchLink>; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America.<br /><searchLink fieldCode="AU" term="%22Albayrak+A%22">Albayrak A</searchLink>; Health Catalyst, Salt Lake City, Utah, United States of America.<br /><searchLink fieldCode="AU" term="%22Asubonteng+J%22">Asubonteng J</searchLink>; Gilead Science, Inc. Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Belli+A%22">Belli A</searchLink>; COTA, Inc., Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Brown+T%22">Brown T</searchLink>; Syapse, San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Cho+K%22">Cho K</searchLink>; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Das+R%22">Das R</searchLink>; Dascena, Oakland, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Eldridge+E%22">Eldridge E</searchLink>; Health Catalyst, Salt Lake City, Utah, United States of America.<br /><searchLink fieldCode="AU" term="%22Gatto+N%22">Gatto N</searchLink>; Aetion, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Gelman+A%22">Gelman A</searchLink>; Health Catalyst, Salt Lake City, Utah, United States of America.<br /><searchLink fieldCode="AU" term="%22Gerlovin+H%22">Gerlovin H</searchLink>; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Goldberg+SL%22">Goldberg SL</searchLink>; Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.<br /><searchLink fieldCode="AU" term="%22Hansen+E%22">Hansen E</searchLink>; COTA, Inc., Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Hirsch+J%22">Hirsch J</searchLink>; Syapse, San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Ho+YL%22">Ho YL</searchLink>; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Ip+A%22">Ip A</searchLink>; Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States of America.<br /><searchLink fieldCode="AU" term="%22Izano+M%22">Izano M</searchLink>; Syapse, San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Jones+J%22">Jones J</searchLink>; Health Catalyst, Salt Lake City, Utah, United States of America.<br /><searchLink fieldCode="AU" term="%22Justice+AC%22">Justice AC</searchLink>; VA Connecticut Healthcare System, West Haven, Connecticut, United States of America.; Yale University Schools of Medicine and Public Health, New Haven, Connecticut, United States of America.<br /><searchLink fieldCode="AU" term="%22Klesh+R%22">Klesh R</searchLink>; HealthVerity, Philadelphia, Pennsylvania, United States of America.<br /><searchLink fieldCode="AU" term="%22Kuranz+S%22">Kuranz S</searchLink>; TriNetX, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Lam+C%22">Lam C</searchLink>; Dascena, Oakland, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Mao+Q%22">Mao Q</searchLink>; Dascena, Oakland, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Mataraso+S%22">Mataraso S</searchLink>; Dascena, Oakland, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Mera+R%22">Mera R</searchLink>; Gilead Science, Inc. Foster City, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Posner+DC%22">Posner DC</searchLink>; Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Rassen+JA%22">Rassen JA</searchLink>; Aetion, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Siefkas+A%22">Siefkas A</searchLink>; Dascena, Oakland, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Schrag+A%22">Schrag A</searchLink>; Syapse, San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Tourassi+G%22">Tourassi G</searchLink>; National Center for Computational Sciences Oak Ridge National Laboratory, Oak Ridge, Tennessee, United States of America.<br /><searchLink fieldCode="AU" term="%22Weckstein+A%22">Weckstein A</searchLink>; Aetion, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Wolf+F%22">Wolf F</searchLink>; Syapse, San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Bhat+A%22">Bhat A</searchLink>; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America.<br /><searchLink fieldCode="AU" term="%22Winckler+S%22">Winckler S</searchLink>; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America.<br /><searchLink fieldCode="AU" term="%22Sigal+EV%22">Sigal EV</searchLink>; Friends of Cancer Research, Washington, District of Columbia, United States of America.; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America.<br /><searchLink fieldCode="AU" term="%22Allen+J%22">Allen J</searchLink>; Friends of Cancer Research, Washington, District of Columbia, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2021 Mar 17; Vol. 16 (3), pp. e0248128. <i>Date of Electronic Publication: </i>2021 Mar 17 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33730088 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0248128 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0248128 Titles: – TitleFull: COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Stewart M – PersonEntity: Name: NameFull: Rodriguez-Watson C – PersonEntity: Name: NameFull: Albayrak A – PersonEntity: Name: NameFull: Asubonteng J – PersonEntity: Name: NameFull: Belli A – PersonEntity: Name: NameFull: Brown T – PersonEntity: Name: NameFull: Cho K – PersonEntity: Name: NameFull: Das R – PersonEntity: Name: NameFull: Eldridge E – PersonEntity: Name: NameFull: Gatto N – PersonEntity: Name: NameFull: Gelman A – PersonEntity: Name: NameFull: Gerlovin H – PersonEntity: Name: NameFull: Goldberg SL – PersonEntity: Name: NameFull: Hansen E – PersonEntity: Name: NameFull: Hirsch J – PersonEntity: Name: NameFull: Ho YL – PersonEntity: Name: NameFull: Ip A – PersonEntity: Name: NameFull: Izano M – PersonEntity: Name: NameFull: Jones J – PersonEntity: Name: NameFull: Justice AC – PersonEntity: Name: NameFull: Klesh R – PersonEntity: Name: NameFull: Kuranz S – PersonEntity: Name: NameFull: Lam C – PersonEntity: Name: NameFull: Mao Q – PersonEntity: Name: NameFull: Mataraso S – PersonEntity: Name: NameFull: Mera R – PersonEntity: Name: NameFull: Posner DC – PersonEntity: Name: NameFull: Rassen JA – PersonEntity: Name: NameFull: Siefkas A – PersonEntity: Name: NameFull: Schrag A – PersonEntity: Name: NameFull: Tourassi G – PersonEntity: Name: NameFull: Weckstein A – PersonEntity: Name: NameFull: Wolf F – PersonEntity: Name: NameFull: Bhat A – PersonEntity: Name: NameFull: Winckler S – PersonEntity: Name: NameFull: Sigal EV – PersonEntity: Name: NameFull: Allen J IsPartOfRelationships: – BibEntity: Dates: – D: 17 M: 03 Text: 2021 Mar 17 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 16 – Type: issue Value: 3 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |
